Profusa, Inc. (PFSA): Entry into a Material Definitive Agreement
Profusa, Inc. (PFSA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Senior Secured Convertible Promissory Note On September 16, 2026, Profusa, Inc., a Delaware corporation (the “Company”), completed an additional closing under that certain Securities Purchase Agreement, dated as of February 11
How this was made
The 30-second read
Why it matters
The financing provides immediate capital but introduces conversion risk and a mandatory prepayment clause, which may affect share price and investor sentiment.
Market read
Primary micro‑cap financing news; limited broader market impact.
What to watch
Potential future conversion if share price rises above $4.28 could increase dilution beyond current expectations.
Background
Profusa Inc. (PFSA) filed a Form 8‑K detailing a senior secured convertible promissory note issuance as part of its securities purchase agreement with Ascent Partners Fund.
Ticker impact
Profusa filed an 8‑K reporting issuance of a $384,615 senior secured convertible promissory note with 7% interest and a $4.28 conversion price.
Potential slight downside as market prices in the new obligation; upside if conversion terms are viewed favorably.
Small raise for a micro‑cap; impact limited to liquidity and dilution considerations.
Market effects
Minimal effect on the broader biotech/diagnostics sector; similar firms may see comparable financing trends.
Limited to U.S. micro‑cap market; no broader regional impact.
Low global relevance; isolated to Profusa shareholders.
Counterpoint
The note’s conversion floor and mandatory prepayment could constrain upside, suggesting a cautious stance.
Key entities
- companyProfusa, Inc.
Issuer of the convertible note.
- investorAscent Partners Fund LLC
Purchaser and collateral agent for the note.